Your browser doesn't support javascript.
Development of Optimized Vitrification Procedures Using Closed Carrier System to Improve the Survival and Developmental Competence of Vitrified Mouse Oocytes.
Park, Jae Kyun; Lee, Ju Hee; Park, Eun A; Lim, Hyunjung J; Lyu, Sang Woo; Lee, Woo Sik; Kim, Jayeon; Song, Haengseok.
  • Park JK; Department of Biomedical Sciences, CHA University, Seongnam 13488, Korea.
  • Lee JH; CHA Fertility Center Gangnam, CHA University, Seoul 06125, Korea.
  • Park EA; Department of Biomedical Sciences, CHA University, Seongnam 13488, Korea.
  • Lim HJ; CHA Fertility Center Seoul Station, CHA University, Seoul 04637, Korea.
  • Lyu SW; Department of Veterinary Medicine, School of Veterinary Medicine, Konkuk University, Seoul 05029, Korea.
  • Lee WS; CHA Fertility Center Gangnam, CHA University, Seoul 06125, Korea.
  • Kim J; CHA Fertility Center Gangnam, CHA University, Seoul 06125, Korea.
  • Song H; CHA Fertility Center Seoul Station, CHA University, Seoul 04637, Korea.
Cells ; 10(7)2021 07 02.
Article in English | MEDLINE | ID: covidwho-1323125
ABSTRACT
The open carrier system (OC) is used for vitrification due to its high efficiency in preserving female fertility, but concerns remain that it bears possible risks of cross-contamination. Closed carrier systems (CC) could be an alternative to the OC to increase safety. However, the viability and developmental competence of vitrified/warmed (VW) oocytes using the CC were significantly lower than with OC. We aimed to improve the efficiency of the CC. Metaphase II oocytes were collected from mice after superovulation and subjected to in vitro fertilization after vitrification/warming. Increasing the cooling/warming rate and exposure time to cryoprotectants as key parameters for the CC effectively improved the survival rate and developmental competence of VW oocytes. When all the conditions that improved the outcomes were applied to the conventional CC, hereafter named the modified vitrification/warming procedure using CC (mVW-CC), the viability and developmental competence of VW oocytes were significantly improved as compared to those of VW oocytes in the CC. Furthermore, mVW-CC increased the spindle normality of VW oocytes, as well as the cell number of blastocysts developed from VW oocytes. Collectively, our mVW-CC optimized for mouse oocytes can be utilized for humans without concerns regarding possible cross-contamination during vitrification in the future.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Oocytes / Blastocyst / Fertilization in Vitro / Cryopreservation / Vitrification Type of study: Prognostic study / Randomized controlled trials Limits: Animals Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Oocytes / Blastocyst / Fertilization in Vitro / Cryopreservation / Vitrification Type of study: Prognostic study / Randomized controlled trials Limits: Animals Language: English Year: 2021 Document Type: Article